BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 28723775)

  • 21. The implication of interferon-γ-producing immunocompetent cells for evaluating disease activity and severity in adult-onset Still's disease.
    Ichikawa T; Shimojima Y; Kishida D; Ueno KI; Sekijima Y
    Int J Rheum Dis; 2021 Sep; 24(9):1176-1185. PubMed ID: 34241971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort.
    Ruscitti P; Iacono D; Ciccia F; Emmi G; Cipriani P; Grembiale RD; Perosa F; Emmi L; Triolo G; Giacomelli R; Valentini G
    J Rheumatol; 2018 Jun; 45(6):864-872. PubMed ID: 29657144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum β2-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset Still's disease.
    Wakabayashi K; Inokuma S; Matsubara E; Onishi K; Asashima H; Nakachi S; Hagiwara K
    Clin Rheumatol; 2013 Jul; 32(7):999-1005. PubMed ID: 23504210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage activation syndrome associated with adult-onset Still's disease: a multicenter retrospective analysis.
    Wang R; Li T; Ye S; Tan W; Zhao C; Li Y; de Bao C; Fu Q
    Clin Rheumatol; 2020 Aug; 39(8):2379-2386. PubMed ID: 32130578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case Report: A Rare Case of Elderly-Onset Adult-Onset Still's Disease in a Patient With Systemic Lupus Erythematosus.
    Hirooka Y; Okuda S; Sugiyama M; Shiga T; Nozaki Y; Kinoshita K; Funauchi M; Matsumura I
    Front Immunol; 2022; 13():822169. PubMed ID: 35116046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.
    Chen DY; Chen YM; Lin CC; Hsieh CW; Wu YC; Hung WT; Chen HH; Lan JL
    BMC Musculoskelet Disord; 2015 May; 16():111. PubMed ID: 25956266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adult-onset Still's disease.
    Gerfaud-Valentin M; Jamilloux Y; Iwaz J; Sève P
    Autoimmun Rev; 2014 Jul; 13(7):708-22. PubMed ID: 24657513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset Still's disease: A multicenter retrospective study.
    Kirino Y; Kawaguchi Y; Tada Y; Tsukamoto H; Ota T; Iwamoto M; Takahashi H; Nagasawa K; Takei S; Horiuchi T; Ichida H; Minota S; Ueda A; Ohta A; Ishigatsubo Y
    Mod Rheumatol; 2018 Sep; 28(5):858-864. PubMed ID: 29278009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adult-onset Still's disease presenting as fever of unknown origin: a single-center retrospective observational study from China.
    Zhang M; Wang Y; Li J; Zhou J
    Ann Palliat Med; 2020 Sep; 9(5):2786-2792. PubMed ID: 32921079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease.
    Kim HA; An JM; Nam JY; Jeon JY; Suh CH
    J Rheumatol; 2012 Jul; 39(7):1399-406. PubMed ID: 22660800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delta neutrophil index as an early marker for differential diagnosis of adult-onset Still's disease and sepsis.
    Park HJ; Ha YJ; Pyo JY; Park YB; Lee SK; Lee SW
    Yonsei Med J; 2014 May; 55(3):753-9. PubMed ID: 24719144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of the international league against rheumatism classification criteria for systemic juvenile idiopathic arthritis as a prognostic factor in patients with adults-onset Still's disease.
    Yang JW; Lee E; Seo JY; Jung JY; Suh CH; Kim HA
    Pediatr Rheumatol Online J; 2018 Jan; 16(1):9. PubMed ID: 29370863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Latent class analysis of 216 patients with adult-onset Still's disease.
    Sugiyama T; Furuta S; Hiraguri M; Ikeda K; Inaba Y; Kagami SI; Kita Y; Kobayashi K; Kobayashi Y; Kurasawa K; Nakagomi D; Nawata Y; Kawasaki Y; Shiko Y; Sugiyama T; Nakajima H
    Arthritis Res Ther; 2022 Jan; 24(1):7. PubMed ID: 34980244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
    Kötter I; Wacker A; Koch S; Henes J; Richter C; Engel A; Günaydin I; Kanz L
    Semin Arthritis Rheum; 2007 Dec; 37(3):189-97. PubMed ID: 17583775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course.
    Wang Z; Chi H; Sun Y; Teng J; Feng T; Liu H; Cheng X; Ye J; Shi H; Hu Q; Jia J; Liu T; Wan L; Zhou Z; Qiao X; Yang C; Su Y
    Rheumatology (Oxford); 2020 Nov; 59(11):3293-3302. PubMed ID: 32276274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proposal of a new diagnostic algorithm for adult-onset Still's disease.
    Daghor-Abbaci K; Ait Hamadouche N; Makhloufi CD; Mechid F; Otmani F; Makrelouf M; Otmane A; Smail N; Boucelma M; Aissat FZ; Lefkir-Teffiani S; Bengana B; Boukheris N; Tebaibia A; Taharbouchet B; Ayoub S; Benziane B; Oumnia N; Haouichet C; Hanni F; Laraba N; Hakem D; Benfenatki N; Berrah A
    Clin Rheumatol; 2023 Apr; 42(4):1125-1135. PubMed ID: 36694091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease.
    Bae CB; Suh CH; An JM; Jung JY; Jeon JY; Nam JY; Kim HA
    J Rheumatol; 2014 Dec; 41(12):2403-8. PubMed ID: 25274901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baseline clinical features predicting macrophage activation syndrome in patients with systemic adult-onset Still's disease receiving interleukin-6 inhibitor treatment.
    Naniwa T; Yamabe T; Ohmura SI; Uehara K; Tamechika SY; Maeda S; Isogai S; Wada J
    Int J Rheum Dis; 2022 Sep; 25(9):1003-1012. PubMed ID: 35719030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adult-onset Still's disease: how to make a diagnosis in an atypical case.
    Hu Q; Yan Z; Zhong J
    Rheumatol Int; 2012 Oct; 32(10):3299-302. PubMed ID: 21877245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive factors and prognosis of macrophage activation syndrome associated with adult-onset Still's disease.
    Yang XP; Wang M; Li TF; Li W; Zhang L; Liu SY
    Clin Exp Rheumatol; 2019; 37 Suppl 121(6):83-88. PubMed ID: 31287402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.